17th Jul 2018 07:00
FOR IMMEDIATE RELEASE 17 July 2018
Cello Health plc
("Cello" or the "Group")
Change of registered office
Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, announces that, with effect from 16 July 2018, the address of its registered office, and corporate headquarters, has changed to Queens House, 8-9 Queen Street, London EC4N 1SP.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director
| |
Cenkos Securities plc | 020 7397 8900 |
Mark Connelly Harry Hargreaves | |
Buchanan Mark Court | 020 7466 5000 |
Jamie Hooper | |
Sophie Wills | |
| |
About Cello Health plc
We are a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
We enable clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. We deliver our services through nearly 1,000 highly skilled professionals utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York, Philadelphia, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com
Related Shares:
CLL.L